5 Jan 2022 Pfizer to Provide U.S. Government with an Additional 10 Million Treatment Courses of its Oral Therapy to Help Combat COVID-19 Press Releases
5 Jan 2022 Dr. Hubert Chen Joins ADARx Pharmaceuticals as Chief Medical Officer Press Releases SAN DIEGO–…
5 Jan 2022 Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine Press Releases NEW…
5 Jan 2022 FDA Accepts Samsung Bioepis’ and Organon’s sBLA for their Citrate-Free, High-Concentration HUMIRA® (Adalimumab) Biosimilar Candidate Press Releases
5 Jan 2022 Repare Therapeutics Expands Executive Leadership Team with the Appointment of Philip Herman as EVP Commercial & New Product Development Press Releases CAMBRIDGE, Mass. & MONTREAL–(
5 Jan 2022 Nationally Recognized Ophthalmologist Dr. Elizabeth Yeu Joins Avellino’s Board of Directors Press Releases MENLO…
5 Jan 2022 FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to AlloVir’s Posoleucel for the Treatment of Adenovirus (AdV) Infections in Adults and Children Post-Allogeneic Stem Cell Transplantation Press Releases